FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3193012657> ?p ?o ?g. }

• W3193012657 endingPage "089719002110382" @default.
• W3193012657 startingPage "089719002110382" @default.
• W3193012657 abstract "Background Omalizumab is currently approved for the treatment of moderate-to-severe allergic asthma in patients 6 years and older. Objective To assess the effectiveness and safety of subcutaneous omalizumab as an add-on therapy option for moderate–severe allergic asthma in patients aged 6—20 years old. Methods The studies published from July, 1970 to May, 2021 were searched from the electronic databases which followed keywords: (“anti-IgE” OR “anti-immunoglobulin E” OR “anti-IgE antibody” OR “omalizumab” OR “rhuMAb-E25” OR “Xolair”) AND “asthma” AND (“child” OR “children” OR “adolescents” OR “youth” OR “teenager” OR “kids” OR “pediatric”). Thirteen studies were pooled to determine the effectiveness and safety of omalizumab. Efficacy endpoints were evaluated using a fixed-effects model or a random-effects model depending on heterogeneity. Safety endpoints were evaluated by odds ratio. Results Thirteen studies were included. In this meta-analysis, our results showed that fractional exhaled nitric oxide and asthma control test scores were significantly improved with omalizumab treatment. Serum immunoglobulin E was also decreased in children with moderate-to-severe asthma after treatment with omalizumab. The analysis found that there was no significant difference between pre-and post-treatment in forced expiratory volume in one second/ forced vital capacity ratio, forced expiratory flow between 25 and 75% of vital capacity, or FEV1. Overall, more adverse events occurred with omalizumab compared to placebo. However, the degree was mild to moderate. Conclusion This meta-analysis indicates that omalizumab is safe and effective to treat children and adolescents with moderate-to-severe asthma." @default.
• W3193012657 created "2021-08-16" @default.
• W3193012657 creator A5001032634 @default.
• W3193012657 creator A5015676515 @default.
• W3193012657 creator A5049161115 @default.
• W3193012657 creator A5067326175 @default.
• W3193012657 creator A5090921153 @default.
• W3193012657 date "2021-08-12" @default.
• W3193012657 modified "2023-10-16" @default.
• W3193012657 title "Effectiveness and Safety Studies of Omalizumab in Children and Adolescents With Moderate-To-Severe Asthma" @default.
• W3193012657 cites W1835232554 @default.
• W3193012657 cites W1930827660 @default.
• W3193012657 cites W1978719586 @default.
• W3193012657 cites W1979423827 @default.
• W3193012657 cites W1980550414 @default.
• W3193012657 cites W1983761933 @default.
• W3193012657 cites W1983832849 @default.
• W3193012657 cites W2020989669 @default.
• W3193012657 cites W2029587541 @default.
• W3193012657 cites W2041651163 @default.
• W3193012657 cites W2074435841 @default.
• W3193012657 cites W2090816517 @default.
• W3193012657 cites W2098276532 @default.
• W3193012657 cites W2109373190 @default.
• W3193012657 cites W2114436422 @default.
• W3193012657 cites W2123002410 @default.
• W3193012657 cites W2136710755 @default.
• W3193012657 cites W2141343329 @default.
• W3193012657 cites W2146852572 @default.
• W3193012657 cites W2160953471 @default.
• W3193012657 cites W2162267840 @default.
• W3193012657 cites W2192072888 @default.
• W3193012657 cites W2267379549 @default.
• W3193012657 cites W2493346890 @default.
• W3193012657 cites W2601782539 @default.
• W3193012657 cites W2631158800 @default.
• W3193012657 cites W2806853209 @default.
• W3193012657 cites W2908300560 @default.
• W3193012657 cites W2922666980 @default.
• W3193012657 cites W2991620982 @default.
• W3193012657 cites W3016000710 @default.
• W3193012657 cites W3022461787 @default.
• W3193012657 cites W3094541642 @default.
• W3193012657 cites W4237066031 @default.
• W3193012657 doi "https://doi.org/10.1177/08971900211038251" @default.
• W3193012657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34384308" @default.
• W3193012657 hasPublicationYear "2021" @default.
• W3193012657 type Work @default.
• W3193012657 sameAs 3193012657 @default.
• W3193012657 citedByCount "0" @default.
• W3193012657 crossrefType "journal-article" @default.
• W3193012657 hasAuthorship W3193012657A5001032634 @default.
• W3193012657 hasAuthorship W3193012657A5015676515 @default.
• W3193012657 hasAuthorship W3193012657A5049161115 @default.
• W3193012657 hasAuthorship W3193012657A5067326175 @default.
• W3193012657 hasAuthorship W3193012657A5090921153 @default.
• W3193012657 hasConcept C126322002 @default.
• W3193012657 hasConcept C141105273 @default.
• W3193012657 hasConcept C142724271 @default.
• W3193012657 hasConcept C156957248 @default.
• W3193012657 hasConcept C159654299 @default.
• W3193012657 hasConcept C165637977 @default.
• W3193012657 hasConcept C187212893 @default.
• W3193012657 hasConcept C197934379 @default.
• W3193012657 hasConcept C203014093 @default.
• W3193012657 hasConcept C204787440 @default.
• W3193012657 hasConcept C27081682 @default.
• W3193012657 hasConcept C2776042228 @default.
• W3193012657 hasConcept C2777714996 @default.
• W3193012657 hasConcept C2778564945 @default.
• W3193012657 hasConcept C2780769369 @default.
• W3193012657 hasConcept C2781142857 @default.
• W3193012657 hasConcept C3018587741 @default.
• W3193012657 hasConcept C55520419 @default.
• W3193012657 hasConcept C71924100 @default.
• W3193012657 hasConceptScore W3193012657C126322002 @default.
• W3193012657 hasConceptScore W3193012657C141105273 @default.
• W3193012657 hasConceptScore W3193012657C142724271 @default.
• W3193012657 hasConceptScore W3193012657C156957248 @default.
• W3193012657 hasConceptScore W3193012657C159654299 @default.
• W3193012657 hasConceptScore W3193012657C165637977 @default.
• W3193012657 hasConceptScore W3193012657C187212893 @default.
• W3193012657 hasConceptScore W3193012657C197934379 @default.
• W3193012657 hasConceptScore W3193012657C203014093 @default.
• W3193012657 hasConceptScore W3193012657C204787440 @default.
• W3193012657 hasConceptScore W3193012657C27081682 @default.
• W3193012657 hasConceptScore W3193012657C2776042228 @default.
• W3193012657 hasConceptScore W3193012657C2777714996 @default.
• W3193012657 hasConceptScore W3193012657C2778564945 @default.
• W3193012657 hasConceptScore W3193012657C2780769369 @default.
• W3193012657 hasConceptScore W3193012657C2781142857 @default.
• W3193012657 hasConceptScore W3193012657C3018587741 @default.
• W3193012657 hasConceptScore W3193012657C55520419 @default.
• W3193012657 hasConceptScore W3193012657C71924100 @default.
• W3193012657 hasLocation W31930126571 @default.
• W3193012657 hasLocation W31930126572 @default.
• W3193012657 hasOpenAccess W3193012657 @default.
• W3193012657 hasPrimaryLocation W31930126571 @default.

• next